Life Science IPOs: Discounts, Then Downgrades
You may also be interested in...
Reformulation Firms Aim To Deliver Better Biotech IPOs In 2011
Can biotech breakthrough the IPO malaise in 2011 with new formulations?
US FDA And NIST Form Partnership To Boost Advanced Manufacturing Techniques
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: